Evidence map›Paper›PMID 41289330›Full record

ArticlePLOS global public health2025

Improving training on hepatitis B research in Nigeria: Findings from an innovation bootcamp to strengthen capacity.

Maria A Afadapa, Olufunto A Olusanya, Peter Kalulu, Nkiruka Obodoechina, Sonam J Shah, Temitope Ojo, Abideen Salako, Joseph Ogbeh, Folahanmi T Akinsolu, Ucheoma Nwaozuru and 14 more

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Maria A AfadapaDepartment of Medicine, Washington University in Saint Louis, St. Louis, Missouri, United States of America.ORCID https://orcid.org/0000-0002-1547-989X
Olufunto A OlusanyaDepartment of Medicine, Washington University in Saint Louis, St. Louis, Missouri, United States of America.
Peter KaluluDepartment of Medicine, Washington University in Saint Louis, St. Louis, Missouri, United States of America.
Nkiruka ObodoechinaDepartment of Medicine, Washington University in Saint Louis, St. Louis, Missouri, United States of America.
Sonam J ShahDepartment of Pediatric Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America.
Temitope OjoDepartment of Medicine, Washington University in Saint Louis, St. Louis, Missouri, United States of America.
Abideen SalakoDepartment of Clinical Research, Nigeria Institute of Medical Research, Lagos, Nigeria.
Joseph OgbehDepartment of Clinical Research, Nigeria Institute of Medical Research, Lagos, Nigeria.ORCID https://orcid.org/0009-0001-7074-3788
Folahanmi T AkinsoluDepartment of Clinical Research, Nigeria Institute of Medical Research, Lagos, Nigeria.
Ucheoma NwaozuruDepartment of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America.
Adesola Z MusaDepartment of Clinical Research, Nigeria Institute of Medical Research, Lagos, Nigeria.
Titilola Gbaja-BiamilaDepartment of Clinical Research, Nigeria Institute of Medical Research, Lagos, Nigeria.
Olaitan H OlayiwolaDepartment of Medicine, College of Medicine, University of Ibadan, Oyo, Nigeria.ORCID https://orcid.org/0009-0006-1777-0732
Idris A OladosuDepartment of Medicine, College of Medicine, University of Ibadan, Oyo, Nigeria.ORCID https://orcid.org/0000-0002-7706-8260
Suzanne DayDepartment of Pediatric Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America.ORCID https://orcid.org/0000-0001-7546-8749
Peyton ThompsonDepartment of Pediatric Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America.ORCID https://orcid.org/0000-0002-9679-9763
Kristie FoleyDepartment of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America.
Oluwaseun Falade-NwuliaDepartment of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Dan WuDepartment of Pediatric Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America.
Olufunmilayo LesiDepartment of HIV, Hepatitis & STIs, World Health Organization Regional Office for Africa, Geneva, Switzerland.
Collins O AirhihenbuwaDepartment of Health Policy and Behavioral Science, Georgia State University School of Public Health, Atlanta, Georgia, United States of America.
Joseph D TuckerDepartment of Pediatric Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America.
Oliver EzechiDepartment of Clinical Research, Nigeria Institute of Medical Research, Lagos, Nigeria.
Juliet IwelunmorDepartment of Medicine, Washington University in Saint Louis, St. Louis, Missouri, United States of America.

Funding

US-Nigerian Cancer Control Center for Research on Implementation Science Excellence (C3-RISE)U54CA284110 · NCI · WASHINGTON UNIVERSITY · PI OLIVER CHUKWUJEKWU EZECHI, Juliet Iwelunmor · 2023 to 2026
$5.0M
NCI NIH HHS U54 CA284110World Health Organization 001
6 · The paper itself

Abstract

We organized an Innovation Bootcamp for young people in Nigeria to develop strategies promoting the uptake of the hepatitis B birth dose vaccine among newborns, which remains low, with an estimated coverage of 52%. This event was a collaborative, cross-disciplinary capacity-building platform to generate creative solutions addressing barriers to Hepatitis B vaccine uptake. The purpose of this study was to describe the bootcamp activities that address this gap and evaluate the impact of an Innovation Bootcamp designed to build research capacity among young Nigerians. The bootcamp was informed by Participatory Action Research focused at engaging young people as co-researchers to investigate and address issues affecting their respective communities using the PEN-3 cultural model. Qualitative data from the community needs assessment were analyzed using a thematic analysis framework to identify and synthesize emerging themes. Socio-demographic characteristics of the participants were collected, and a pre- and post-survey was administered. The participants' knowledge of hepatitis B and research skills were compared using the Wilcoxon test. Our results included five teams composed of fifteen participants with a mean age of 25.5 years, originating from the Southern regions of Nigeria. The post-survey showed significant improvements in participants' knowledge and research skills, with knowledge increasing by 21.6% (mean score: 39.7 to 48.3, p = 0.010) and research skills by 36.4% (mean score: 56.1 to 76.5, p < 0.001). Each team co-designed implementation strategies, including referral pathways from traditional birth attendants to formal health centers, comprehensive training workshops, and trusted community leaders as vaccination ambassadors. In conclusion, the bootcamp demonstrated its effectiveness in strengthening capacity and increasing knowledge (although in a small sample size), which contributed to informing the development of implementation strategies. Findings from the pilot studies will ultimately inform future research focused on promoting and sustaining youth-derived vaccination service delivery strategies in Nigeria.

Identifiers

PMID41289330
PMCPMC12646463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.